The Phytoalexin Resveratrol Ameliorates Ochratoxin A Toxicity in Human Embryonic Kidney (HEK293) Cells

Journal of Cellular Biochemistry

Volumn 116, Issue 12, 2015, Pages 2947-2955

  Raghubeer, Shanel ^a   Nagiah, Savania ^a   Phulukdaree, Alisa ^b   Chuturgoon, Anil ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

HEK293 CELLS; L ON P1; OCHRATOXIN A; OXIDATIVE STRESS; RESVERATROL

Indexed keywords

GLUTATHIONE; LONP1 PROTEIN; OCHRATOXIN; PROTEIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; SIRTUIN 1; SIRTUIN 3; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NRF2; TRANSCRIPTION FACTOR OGG1; UNCLASSIFIED DRUG; ADENOSINE TRIPHOSPHATE DEPENDENT PROTEINASE; DNA GLYCOSYLTRANSFERASE; LONP1 PROTEIN, HUMAN; MITOCHONDRIAL PROTEIN; OXOGUANINE GLYCOSYLASE 1, HUMAN; PHYTOALEXINS; SESQUITERPENE; STILBENE DERIVATIVE;

ARTICLE; COMET ASSAY; COMPARATIVE STUDY; CYTOTOXICITY; DNA DAMAGE; DNA STRAND BREAKAGE; EMBRYO; FLOW CYTOMETRY; GENE EXPRESSION; HEK293 CELL LINE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IC50; MTT ASSAY; OXIDATIVE STRESS; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; WESTERN BLOTTING; APOPTOSIS; ASPERGILLUS; BALKAN NEPHROPATHY; BIOSYNTHESIS; DRUG EFFECTS; FOOD CONTROL; METABOLISM; PATHOGENICITY; PATHOLOGY; PENICILLIUM;

APOPTOSIS; ASPERGILLUS; ATP-DEPENDENT PROTEASES; BALKAN NEPHROPATHY; DNA DAMAGE; DNA GLYCOSYLASES; FOOD MICROBIOLOGY; HEK293 CELLS; HUMANS; MITOCHONDRIAL PROTEINS; OCHRATOXINS; OXIDATIVE STRESS; PENICILLIUM; REACTIVE OXYGEN SPECIES; SESQUITERPENES; STILBENES;

EID: 84943552765     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25242     Document Type: Article

References (33)

1. Arbillaga L, Azqueta A, Ezpeleta O, Lopez de Cerain A,. 2007. Oxidative DNA damage induced by ochratoxin A in the HK-2 human kidney cell line: Evidence of the relationship with cytotoxicity. Mutagenesis 22: 35-42.
2. Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR, Kim AL,. 2007. Resveratrol: A review of preclinical studies for human cancer prevention. Toxicolo Appl Pharmacol 224: 274-283.
3. Bankole S, Schollenberger M, Drochner W,. 2006. Mycotoxins in food systems in Sub Saharan Africa: A review. Mycotoxin Res 22: 163-169.
4. Baur JA, Sinclair DA,. 2006. Therapeutic potential of resveratrol: The in vivo evidence. Nat Rev Drug Discov 5: 493-506.
5. Borra MT, Smith BC, Denu JM,. 2005. Mechanism of human SIRT1 activation by resveratrol. J Biol Chem 280: 17187-17195.
6. Bota DA, Van Remmen H, Davies KJA,. 2002. Modulation of Lon protease activity and aconitase turnover during aging and oxidative stress. FEBS Lett 532: 103-106.
7. Castegnaro M, Canadas D, Vrabcheva T, Petkova-Bocharova T, Chernozemsky IN, Pfohl-Leszkowicz A,. 2006. Balkan endemic nephropathy: Role of ochratoxins A through biomarkers. Mol Nutr Food Res 50: 519-529.
8. Cavin C, Delatour T, Marin-Kuan M, Holzhauser D, Higgins L, Bezencon C, Guignard G, Junod S, Richoz-Payot J, Gremaud E,. 2007. Reduction in antioxidant defenses may contribute to ochratoxin A toxicity and carcinogenicity. Toxicol Sci 96: 30-39.
9. Cheng Y, Ren X, Gowda AS, Shan Y, Zhang L, Yuan Y-S, Patel R, Wu H, Huber-Keener K, Yang JW,. 2013. Interaction of Sirt3 with OGG1 contributes to repair of mitochondrial DNA and protects from apoptotic cell death under oxidative stress. Cell Death & Disease 4.
10. Gibellini L, Pinti M, Beretti F, Pierri CL, Onofrio A, Riccio M, Carnevale G, De Biasi S, Nasi M, Torelli F,. 2014. Sirtuin 3 interacts with Lon protease and regulates its acetylation status. Mitochondrion 18: 76-81.
11. Hohler D, Sudekum KH, Wolffram S, Frohlich AA, Marquardt RR,. 1999. Metabolism and excretion of ochratoxin A fed to sheep. J Anim Sci 77: 1217-1223.
12. Jonsyn-Ellis F, 2012. Ochratoxin A: Any cause for concern in Sub Saharan Africa? Sci J Environ Eng Res 2012: 5.
13. Livak KJ, Schmittgen TD,. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408.
14. Marin-Kuan M, Cavin C, Delatour T, Schilter B,. 2008. Ochratoxin A carcinogenicity involves a complex network of epigenetic mechanisms. Toxicon 52: 195-202.
15. Marin-Kuan M, Ehrlich V, Delatour T, Cavin C, Schilter B,. 2011. Evidence for a role of oxidative stress in the carcinogenicity of ochratoxin A. Journal of Toxicology 2011.
16. Meyer JN, Leung MCK, Rooney JP, Sendoel A, Hengartner MO, Kisby GE, Bess AS,. 2013. Mitochondria as a target of environmental toxicants. Toxicol Sci 134: 1-17.
17. Momchilova A, Petkova D, Staneva G, Markovska T, Pankov R, Skrobanska R, Nikolova-Karakashian M, Koumanov K,. 2014. Resveratrol alters the lipid composition, metabolism and peroxide level in senescent rat hepatocytes. Chem Biol Interact 207: 74-80.
18. Nasrin N, Kaushik VK, Fortier E, Wall D, Pearson KJ, de Cabo R, Bordone L,. 2009. JNK1 phosphorylates SIRT1 and promotes its enzymatic activity. PLoS One 4: e8414.
19. Nguyen T, Nioi P, Pickett CB,. 2009. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem 284: 13291-13295.
20. Özçelik N, Soyöz M, Kbox drawings light down and leftlbox drawings light down and leftnç ̄,. 2004. Effects of ochratoxin a on oxidative damage in rat kidney: Protective role of melatonin. J Appl Toxicol 24: 211-215.
21. Palma N, Cinelli S, Sapora O, Wilson SH, Dogliotti E,. 2007. Ochratoxin A-induced mutagenesis in mammalian cells is consistent with the production of oxidative stress. Chem Res Toxicol 20: 1031-1037.
22. Pfohl-Leszkowicz A, Manderville RA,. 2007. Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humans. Mol Nutr Food Res 51: 61-99.
23. Rossi D, Guerrini A, Bruni R, Brognara E, Borgatti M, Gambari R, Maietti S, Sacchetti G,. 2012. Trans-Resveratrol in nutraceuticals: Issues in retail quality and effectiveness. Molecules 17: 12393-12405.
24. Sasaki T, Maier B, Koclega KD, Chruszcz M, Gluba W, Stukenberg PT, Minor W, Scrable H,. 2008. Phosphorylation regulates SIRT1 function. PLoS One 3: e4020.
25. Schaaf GJ, Nijmeijer SM, Maas RF, Roestenberg P, de Groene EM, Fink-Gremmels J,. 2002. The role of oxidative stress in the ochratoxin A-mediated toxicity in proximal tubular cells. Biochim Biophys Acta 1588: 149-158.
26. Schilter B, Marin-Kuan M, Delatour T, Nestler S, Mantle P, Cavin C,. 2005. Ochratoxin A: Potential epigenetic mechanisms of toxicity and carcinogenicity. Food Addit Contam 22: 88-93.
27. Timmers S, Auwerx J, Schrauwen P,. 2012. The journey of resveratrol from yeast to human. Aging 4: 146-158.
28. van der Merwe KJ, Steyn PS, Fourie L, Scott DB, Theron JJ,. 1965. Ochratoxin A, a toxic metabolite produced by Aspergillus ochraceus Wilh. Nature 205: 1112-1113.
29. Visconti A, Perrone G, Cozzi G, Solfrizzo M,. 2008. Managing ochratoxin A risk in the grape-wine food chain. Food Addit Contam 25: 193-202.
30. Wang CH, Wu SB, Wu YT, Wei YH,. 2013. Oxidative stress response elicited by mitochondrial dysfunction: Implication in the pathophysiology of aging. Exp Biol Med 238: 450-460.
31. Weydert CJ, Cullen JJ,. 2010. Measurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissue. Nat Protoc 5: 51-66.
32. Wu G, Fang YZ, Yang S, Lupton JR, Turner ND,. 2004. Glutathione metabolism and its implications for health. J Nutr 134: 489-492.
33. Zhang B, Shen XL, Liang R, Li Y, Huang K, Zhao C, Luo Y, Xu W,. 2014. Protective role of the mitochondrial Lon protease 1 in ochratoxin A-induced cytotoxicity in HEK293 cells. J Proteomics 101: 154-168.